{{medical}}
{{lowercase}}
{{Infobox drug class
| Name = β受体阻断药<br/>Beta blockers
| Image = Propranolol-2D-skeletal.png
| Alt = Propranolol
| Use = [[高血压|高血压]]、[[心律不整|心律不整]]等
| Caption = [[普萘洛尔|普萘洛尔]]的[[键线式|键线式]]结构，是第一种成功应用于临床的β受体阻断药
| Biological_target = [[β受体|β受体]]
| ATC_prefix = C07
| MeshID = D000319
| Drugs.com = {{Drugs.com|drug-class|cardioselective-beta-blockers}}
| Consumer_Reports = beta_blockers
| medicinenet = beta_blockers
| rxlist = 90349
}}

'''β受体阻断药'''（{{lang-en|Beta blockers}}），又称'''Beta受体阻断药'''、'''β受体阻断剂'''、'''β受体阻滞剂'''、'''β受体拮抗剂'''或'''β阻断药、乙型阻斷劑'''，是一类用来治疗[[心律不整|心律不整]]、防止[[心脏病|心脏病]]发作后的二次心脏病发作（二级预防）和在某些情况下用来治疗[[高血压|高血压]]的[[药品|药物]]。<ref name="pmid10381708">{{cite journal | author = Freemantle N, Cleland J, Young P, Mason J, Harrison J | title = beta Blockade after myocardial infarction: systematic review and meta regression analysis | journal = BMJ | volume = 318 | issue = 7200 | pages = 1730–7 | date = June 1999 | pmid = 10381708 | pmc = 31101 | doi = 10.1136/bmj.318.7200.1730 }}</ref><ref name="pmid20692524">{{cite journal | author = Cruickshank JM | title = Beta blockers in hypertension | journal = Lancet | volume = 376 | issue = 9739 | pages = 415; author reply 415–6 | date = August 2010 | pmid = 20692524 | doi = 10.1016/S0140-6736(10)61217-2 }}</ref><ref name="UpToDateHypertension">{{cite journal | title=Choice of therapy in primary (essential) hypertension: Clinical trials | author=Kaplan, Norman M. | journal=UpToDate |date=October 2010 }}</ref>近期有相關證據顯示，此類阻滯劑可能具有協助癌症治療的潛能。<ref>{{Cite journal|title=β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up.|url=https://pubmed.ncbi.nlm.nih.gov/28346289/|last=De Giorgi|first=Vincenzoa|last2=Grazzini|first2=Martaa|date=June 2017|journal=Melanoma Research|doi=10.1097/CMR.000000000000031|volume=27|pages=268-270|last3=Benemei|first3=Silviab|last4=Marchionni|first4=Niccolòc|last5=Geppetti|first5=Pierangelob|last6=Gandini|first6=Sarad|access-date=2020-12-21|archive-date=2021-11-19|archive-url=https://web.archive.org/web/20211119011420/https://pubmed.ncbi.nlm.nih.gov/28346289/|dead-url=no}}</ref><ref>{{Cite journal|title=Improving survival rates in two models of spon- taneous postoperative metastasis in mice by combined administration of a β‐adrenergic antagonist and a cyclooxygenase‐2 inhibitor.|url=https://www.jimmunol.org/content/184/5/2449|last=Glasner|first=A|last2=Avraham|first2=R|date=March 2010|journal=Journal of Immunology|doi=10.4049/jimmunol.0903301|volume=184|pages=2449–2457|last3=Rosenne|first3=E|last4=Benish|first4=M|last5=Zmora|first5=O|last6=Shemer|first6=S|last7=Ben‐Eliyahu|first7=S|access-date=2020-12-21|archive-date=2021-11-19|archive-url=https://web.archive.org/web/20211119011518/https://www.jimmunol.org/content/184/5/2449|dead-url=no}}</ref><ref>{{Cite journal|title=β‐Blockers reduce breast cancer recurrence and breast cancer death: A meta‐analysis. Clinical Breast Cancer.|url=https://www.sciencedirect.com/science/article/pii/S1526820915001470?via%3Dihub|last=Childers|first= W. K.|last2=Hollenbeak|first2=C. S.|date=December 2015|journal=Clinical Breast Cancer|doi=10.1016/j.clbc.2015.07.001|volume=15|issue=6|pages=426-431|last3=Cheriyath|first3= P}}</ref>

β受体阻断药[[非竞争性|非竞争性]]阻断[[交感神经系统|交感神经系统]]中内源性[[儿茶酚胺|儿茶酚胺]][[肾上腺素|肾上腺素]]和[[去甲肾上腺素|去甲肾上腺素]]的作用，尤其是肾上腺素能[[β受体|β受体]]。<ref name="urlCurrent Cardiovascular Drugs - Google Books">{{Cite book | url = http://books.google.com/?id=y3R1Vd3NHqcC&pg=PA152&dq=mode+of+action+of+beta+blockers#v=onepage&q=mode%20of%20action%20of%20beta%20blockers&f=false | title = Current Cardiovascular Drugs | author = Frishman W.H. | author2 = Cheng-Lai A | author3 = Nawarskas J | year = 2005 | publisher = Current Science Group | page = 152 | accessdate = 2010-09-07 | isbn = 978-1-57340-221-7 }}</ref><ref name="urlPharmacotherapeutics for advanced ... - Google Books">{{Cite book | url = http://books.google.com/?id=EaP1yJz4fkEC&pg=PA205&dq=beta+receptors+heart+kidneys#v=onepage&q=beta%20receptors%20heart%20kidneys&f=false | title = Pharmacotherapeutics for advanced practice: a practical approach | author = Arcangelo V.P. | author2 = Peterson A.M. | year = 2006 | publisher = Lippincott Williams & Wilkins | page = 205 | accessdate = 2010-09-07 | isbn = 978-0-7817-5784-3 }}</ref>有些药物阻断所有[[β-肾上腺素能受体|β-肾上腺素能受体]]，有些则为竞争性阻断。目前，市面上的藥物多以β受體中的β1及β2為目標，而針對β3的受體阻滯劑因藥理學特性仍無法良好掌握故持續處於研究階段。<ref>{{Cite journal|title=Everything You Always Wanted to Know about β3-AR * (* But Were Afraid to Ask)|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523418/|last=Schena|first= G|last2=Caplan|first2=M. J.|date=Aprail 2019|journal=Cells|doi=10.3390/cells8040357|volume=8|issue=4|pages=357|last3=Benemei|first3=Silviab|last4=Marchionni|first4=Niccolòc|last5=Geppetti|first5=Pierangelob|last6=Gandini|first6=Sarad}}</ref>

ESC/ESH指引指出對於合併心衰竭、心絞痛、心肌梗塞後或心房顫動的高血壓患者，以及育齡期或計畫懷孕的女性高血壓患者，可考慮在任何治療階段使用乙型阻斷劑。<ref>{{Cite journal|title=2018 ESC/ESH Guidelines for the management of arterial hypertensionThe Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)|url=https://academic.oup.com/eurheartj/article/39/33/3021/5079119|last=Williams|first=Bryan|last2=Mancia|first2=Giuseppe|date=2018-09-01|journal=European Heart Journal|issue=33|doi=10.1093/eurheartj/ehy339|volume=39|pages=3021–3104|language=en|issn=0195-668X|last3=Spiering|first3=Wilko|last4=Agabiti Rosei|first4=Enrico|last5=Azizi|first5=Michel|last6=Burnier|first6=Michel|last7=Clement|first7=Denis L.|last8=Coca|first8=Antonio|last9=de Simone|first9=Giovanni|access-date=2020-01-03|archive-date=2022-03-10|archive-url=https://web.archive.org/web/20220310103045/https://academic.oup.com/eurheartj/article/39/33/3021/5079119|dead-url=no}}</ref>

最近有研究證明乙型阻斷劑carvedilol可以增強骨骼肌收縮力，但卻無法導致骨骼肌肥大; 該研究亦指出β2AR激動劑clenbuterol則可以增強骨骼肌收縮力和引起骨骼肌肥大的現象，而這些現象都是通過β-arrestin的信號傳遞所介導的。<ref>{{cite journal |last1=Kim |first1=Jihee |last2=Grotegut |first2=Chad A. |last3=Wisler |first3=James W. |last4=Mao |first4=Lan |last5=Rosenberg |first5=Paul B. |last6=Rockman |first6=Howard A. |last7=Lefkowitz |first7=Robert J. |title=The β-arrestin-biased β-adrenergic receptor blocker carvedilol enhances skeletal muscle contractility |journal=Proceedings of the National Academy of Sciences |date=2020-06-02 |volume=117 |issue=22 |pages=12435–12443 |doi=10.1073/pnas.1920310117}}</ref>

==例子==
[[Image:Dichloroisoprenaline.svg|thumb]]

* [[普萘洛尔|普萘洛尔]]（Propranolol）
* [[毕索洛尔|毕索洛尔]]（Bisoprolol）

==引用==
{{reflist}}


{{主要药物分类}}

[[Category:抗高血压药|Category:抗高血压药]]
[[Category:抗心律不齐药|Category:抗心律不齐药]]
[[Category:Β阻滞药|*]]
[[Category:苏格兰发明|Category:苏格兰发明]]